Lasting Cardiology Guidelines from Randomized Controlled Trials: Penn Study

by Himabindu Venkatakrishnan on May 28, 2014 at 11:34 AM
 Lasting Cardiology Guidelines from Randomized Controlled Trials: Penn Study

New evidence about best practices and clinical outcomes of various treatments can change the clinical practice guideline recommendations for screening and treatment. In a first-of-its-kind study, Penn Medicine researchers examined high-level recommendations published by the American College of Cardiology (ACC) and the American Heart Association (AHA) between 1998 and 2007 and found that recommendations which were supported by multiple randomized controlled trials were the most "durable" and least likely to change over time. Their work will be published in JAMA.

A Penn research team led by Mark D. Neuman, MD, MSc, assistant professor of Anesthesiology and Critical Care and Senior Fellow in the Leonard David Institute of Health Economics, analyzed changes over time in over 600 Class I ACC/AHA recommendations, each of which recommended strongly in favor of a particular treatment or procedure related to cardiovascular disease.


Based on comparisons of serial editions of ACC/AHA guidelines, the authors observed that 4 out of 5 Class I recommendations remained valid across two guideline editions; however, they also noted that 1 out of every 5 Class I recommendations was either downgraded to a less certain status, reversed so as to recommend against a previously endorsed treatment, or omitted entirely.

Neuman and colleagues also found the odds of a downgrade, reversal, or omission to be more than three times greater among recommendations based on retrospective studies, case reports, or expert opinion versus randomized controlled trials.

While the study was not designed to examine the specific reasons that the individual recommendations were downgraded, supplemental analyses suggested that it was uncommon for recommendations to be downgraded as a result of the emergence of new research studies. Instead, Neuman and colleagues found that many of the downgrades in recommendations that they observed may have come from changes over time in how expert physicians interpreted existing medical research.

"Clinical practice guidelines are used by health care providers to make decisions about treatments for individual patients, and by hospitals, regulators, and insurers to develop quality measures," says Neuman. "Our study provides new information about the durability of guideline recommendations over time that can help patients, clinicians, administrators, and regulators make better choices about how guideline recommendations can be used to improve patient outcomes."

Source: Eurekalert
Font : A-A+



Recommended Readings

Latest Clinical Trials News

Plant Chloroplasts Offer Hope for  Huntington's Disease Treatment
A chloroplast plant enzyme - stromal processing peptidase, helps treat Huntington's disease by preventing protein clumping.
'Artificial Wombs' In Human Trials Await FDA Approval
FDA approval is sought for “artificial womb” clinical trials (mimicking lamb trials) in humans, that can potentially reduce mortality in premature babies.
Injecting Platelets Could be as Beneficial as Exercising to the Brain
Increasing the levels of platelet-derived factors in the body may lessen the effect of age-related degenerative changes and cognitive impairment in the brain.
Engineered Bacteria Offer New Hope for Early Cancer Detection
Constructing bacteria to become drug resistant only when they took up DNA containing cancer-associated changes, could be useful in detecting cancer.
Is Eli Lilly's Drug the Future of Obesity Treatment?
Eli Lilly's Mounjaro may prove an alternative to bariatric surgery, stated clinical trial results.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Lasting Cardiology Guidelines from Randomized Controlled Trials: Penn Study Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests